https://www.linkedin.com/jobs/view/3923003878
Global Brand Lead - Pixclara (101CDx)
The Global Brand Lead – Pixclara (Fluorine (18F) floretyrosine) is responsible for the global brand management of the asset and its commercial success. The prime responsibility is leading the multidisciplinary Global Brand Team to develop a global commercial plan for the asset, including defining the business case and target markets. The position is responsible for all activities related to both product planning and product marketing including partnering with the development team to manage the asset throughout the product development, product lifecycle, prioritizing product/customer requirements, defining the product vision, and working closely with all stakeholders to deliver a winning strategy.
Strategic Marketing
Develops vision, positioning and message houseDefines the patient journey, along with the treatment algorithm
Works to develop an overall upstream marketing toolkit
Cross-cultural Strategy
Defines business case /lead indication and target markets on a global level
Develop, maintain and present reporting as required
Works to establish the product roadmap, including the plan, organization and execution for commercial activities of the asset
Ensures regulatory and development strategy aligns to the market access strategy for each region by establishing the value proposition, pricing, and reimbursement for the given area
Collaboration and Leadership
Collaborates as part of a matrixed team prior to Phase 3 trials for deliverables on the assigned asset to ensure desired commercial outcomes
Collaborate and Lead the project with Manufacturing, Medical Affairs, Regulatory Affairs, Supply Chain, and other key stakeholders to ensure seamless communication and integration of commercial strategies throughout the product life cycle
Data-driven Decision Making
Utilizes market research, along with competitive intelligence to make decisions regarding the asset
Manages the product profitability and overall commercial success
Establish and track key performance indicators (KPIs) to evaluate the success of commercialization efforts, providing regular performance reports to senior management
Monitor and act on risks and opportunities, including escalating as appropriate
Bachelor’s degree in marketing, business or life sciences required. Master’s degree or above preferred.
Minimum 10+ years’ experience in developing a global brand strategy in pharmaceuticals working with a cross-functional matrix teams required
Prior experience in managing product development from Phase 2, along with marketing strategy required. Experience with glioblastoma or other brain cancer products preferred.
Exceptional leadership and strategic planning skills, with the ability to drive cross-functional teams towards common goals
Experience in radiopharmaceuticals preferred
Proven track record in launch strategy development and managing pre-launch activities to drive revenue and profitsExcellent analytical and problem-solving abilities, with a data-driven approach to decision-makingOutstanding communication and interpersonal skills to effectively collaborate and lead stakeholders at all levelsDemonstrated ability to adapt to a fast-paced and evolving global market environmentKnowledge of regulatory requirements and compliance in the pharmaceutical industry requiredAbility to conduct competitive environment analysis and understand market segments and customer needs to effectively translate into clear marketing requirementsAbility to advise on business case justifications for new products and improvements of the product portfolio.Experience in delivering finely tuned product upstream marketing strategiesExceptional writing and editing skills, combined with strong presentation and public speaking skillsStrong learning agility and a desire to gain new skills and experience
- Forums
- ASX - By Stock
- TLX
- Understanding Telix
Understanding Telix, page-795
-
- There are more pages in this discussion • 591 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.61 |
Change
0.130(0.70%) |
Mkt cap ! $6.227B |
Open | High | Low | Value | Volume |
$18.69 | $18.80 | $18.37 | $19.72M | 1.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 161 | $18.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.62 | 450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 18.450 |
1 | 108 | 18.430 |
1 | 163 | 18.350 |
1 | 5000 | 18.310 |
3 | 6163 | 18.300 |
Price($) | Vol. | No. |
---|---|---|
18.620 | 450 | 1 |
18.700 | 400 | 1 |
18.900 | 1500 | 1 |
19.010 | 3200 | 2 |
19.050 | 512 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online